Legal & General Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.4M | Buy |
1,062,818
+135,135
| +15% | +$7.43M | 0.01% | 592 |
|
|
2025
Q1 | $65.6M | Buy |
927,683
+66,756
| +8% | +$4.72M | 0.02% | 577 |
|
|
2024
Q4 | $56.6M | Sell |
860,927
-347,663
| -29% | -$22.9M | 0.02% | 595 |
|
|
2024
Q3 | $85M | Sell |
1,208,590
-10,455
| -0.9% | -$735K | 0.02% | 543 |
|
|
2024
Q2 | $100M | Buy |
1,219,045
+108,510
| +10% | +$8.93M | 0.03% | 488 |
|
|
2024
Q1 | $97M | Sell |
1,110,535
-14,501
| -1% | -$1.27M | 0.03% | 503 |
|
|
2023
Q4 | $108M | Sell |
1,125,036
-91,616
| -8% | -$8.83M | 0.03% | 468 |
|
|
2023
Q3 | $108M | Sell |
1,216,652
-1,571
| -0.1% | -$139K | 0.04% | 449 |
|
|
2023
Q2 | $106M | Buy |
1,218,223
+51,426
| +4% | +$4.46M | 0.03% | 467 |
|
|
2023
Q1 | $113M | Sell |
1,166,797
-1,418
| -0.1% | -$138K | 0.04% | 444 |
|
|
2022
Q4 | $121M | Sell |
1,168,215
-63,752
| -5% | -$6.6M | 0.05% | 419 |
|
|
2022
Q3 | $104M | Sell |
1,231,967
-18,925
| -2% | -$1.6M | 0.04% | 452 |
|
|
2022
Q2 | $104M | Buy |
1,250,892
+66,683
| +6% | +$5.53M | 0.04% | 474 |
|
|
2022
Q1 | $91.3M | Buy |
1,184,209
+99,255
| +9% | +$7.65M | 0.03% | 553 |
|
|
2021
Q4 | $95.9M | Sell |
1,084,954
-15,908
| -1% | -$1.41M | 0.03% | 546 |
|
|
2021
Q3 | $85.1M | Sell |
1,100,862
-11,016
| -1% | -$851K | 0.03% | 573 |
|
|
2021
Q2 | $92.8M | Buy |
1,111,878
+20,092
| +2% | +$1.68M | 0.03% | 552 |
|
|
2021
Q1 | $82.4M | Buy |
1,091,786
+3,692
| +0.3% | +$279K | 0.03% | 558 |
|
|
2020
Q4 | $95.4M | Sell |
1,088,094
-38,143
| -3% | -$3.34M | 0.04% | 492 |
|
|
2020
Q3 | $85.7M | Sell |
1,126,237
-5,345
| -0.5% | -$407K | 0.04% | 455 |
|
|
2020
Q2 | $140M | Buy |
1,131,582
+105,804
| +10% | +$13M | 0.07% | 316 |
|
|
2020
Q1 | $86.7M | Buy |
1,025,778
+28,650
| +3% | +$2.42M | 0.05% | 376 |
|
|
2019
Q4 | $84.3M | Buy |
997,128
+41,031
| +4% | +$3.47M | 0.04% | 474 |
|
|
2019
Q3 | $64.4M | Buy |
956,097
+8,538
| +0.9% | +$575K | 0.03% | 513 |
|
|
2019
Q2 | $81.2M | Sell |
947,559
-7,240
| -0.8% | -$620K | 0.04% | 464 |
|
|
2019
Q1 | $84.8M | Buy |
954,799
+207,228
| +28% | +$18.4M | 0.05% | 424 |
|
|
2018
Q4 | $63.7M | Buy |
747,571
+54,131
| +8% | +$4.61M | 0.05% | 411 |
|
|
2018
Q3 | $67.2M | Buy |
693,440
+4,112
| +0.6% | +$399K | 0.05% | 427 |
|
|
2018
Q2 | $64.9M | Sell |
689,328
-31,546
| -4% | -$2.97M | 0.05% | 418 |
|
|
2018
Q1 | $58.4M | Sell |
720,874
-36,589
| -5% | -$2.97M | 0.04% | 460 |
|
|
2017
Q4 | $67.5M | Buy |
757,463
+8,313
| +1% | +$741K | 0.05% | 417 |
|
|
2017
Q3 | $69.7M | Buy |
749,150
+27,752
| +4% | +$2.58M | 0.05% | 387 |
|
|
2017
Q2 | $65.5M | Buy |
721,398
+8,247
| +1% | +$749K | 0.05% | 386 |
|
|
2017
Q1 | $62.6M | Buy |
713,151
+43,302
| +6% | +$3.8M | 0.05% | 383 |
|
|
2016
Q4 | $55.5M | Buy |
669,849
+25,512
| +4% | +$2.11M | 0.05% | 397 |
|
|
2016
Q3 | $59.6M | Buy |
644,337
+828
| +0.1% | +$76.6K | 0.06% | 353 |
|
|
2016
Q2 | $50.1M | Buy |
643,509
+10,228
| +2% | +$796K | 0.05% | 383 |
|
|
2016
Q1 | $52.2M | Sell |
633,281
-3,967
| -0.6% | -$327K | 0.06% | 352 |
|
|
2015
Q4 | $66.8M | Buy |
637,248
+6,133
| +1% | +$643K | 0.08% | 288 |
|
|
2015
Q3 | $66.5M | Buy |
631,115
+43,759
| +7% | +$4.61M | 0.08% | 272 |
|
|
2015
Q2 | $80.3M | Buy |
587,356
+13,052
| +2% | +$1.79M | 0.09% | 244 |
|
|
2015
Q1 | $71.6M | Buy |
574,304
+2,209
| +0.4% | +$275K | 0.09% | 266 |
|
|
2014
Q4 | $51.7M | Sell |
572,095
-28,767
| -5% | -$2.6M | 0.06% | 354 |
|
|
2014
Q3 | $43.4M | Buy |
600,862
+71,376
| +13% | +$5.15M | 0.05% | 403 |
|
|
2014
Q2 | $32.9M | Buy |
529,486
+61,068
| +13% | +$3.8M | 0.04% | 489 |
|
|
2014
Q1 | $32M | Buy |
468,418
+438,400
| +1,460% | +$29.9M | 0.04% | 483 |
|
|
2013
Q4 | $2.11M | Buy |
30,018
+2,835
| +10% | +$199K | ﹤0.01% | 807 |
|
|
2013
Q3 | $1.96M | Buy |
27,183
+4,723
| +21% | +$341K | ﹤0.01% | 807 |
|
|
2013
Q2 | $1.25M | Buy |
+22,460
| New | +$1.25M | ﹤0.01% | 840 |
|